CliffBio
small molecule

PERCORTEN

DESOXYCORTICOSTERONE ACETATE

Loss of exclusivity—loss of exclusivity
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand namePERCORTEN
Active ingredientDESOXYCORTICOSTERONE ACETATE
Strength125MG
Dosage formPELLET
RouteIMPLANTATION
ModalitySmall molecule
Marketing statusDISCN

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.